NCI Community Oncology Research Program
Community Oncology and Prevention Trials
Active, not recruiting
For more information, see ClinicalTrials.gov NCT03860961
This trial studies how well increasing the dose of survivorship care planning improves care and outcomes in prostate cancer survivors receiving radiation therapy and androgen deprivation therapy. There is a need for coordinated care between the cancer care team with the primary care team. This is especially important for prostate cancer survivors who need routine cancer care follow-up with their radiation oncologist and also coordinated routine follow-up with their primary care provider (PCP). This is important because androgen deprivation therapy increases a patient's risk for developing diabetes, hypercholesterolemia, and cardiovascular events. Increasing the dose of survivorship may improve care and outcomes of cancer survivors than standard practices.
Questionnaire Administration, Survivorship Care Plan (SCP), Treatment Plan
Cancer Survivor, Prostate Adenocarcinoma
Ronald C Chen